The pros and cons of safe injection sites for opioids

The sites have saved lives but many worry they're too lax

Protestors in Philadelphia
Protestors in support of safe injection sites in Philadelphia
(Image credit: Cory Clark / NurPhoto via Getty Images)

The United States’ opioid problem has steadily been getting worse. In 2022, more than 110,000 people died of drug overdoses, "two-thirds of whom succumbed to synthetic opioids such as fentanyl," reported The Washington Post. One controversial solution are safe injection sites, described by Scientific American as "places where people who use injectable, but illegal, opioids such as heroin, can do so without fear of overdose, prosecution or spreading disease."

Some facilities have already been established in cities like New York City and San Francisco, while others have banned them. Global research has found benefits to these facilities, but many are still wary about their implications.

Subscribe to The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE
https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg

Sign up for The Week's Free Newsletters

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

Sign up
To continue reading this article...
Continue reading this article and get limited website access each month.
Get unlimited website access, exclusive newsletters plus much more.
Cancel or pause at any time.
Already a subscriber to The Week?
Not sure which email you used for your subscription? Contact us
Devika Rao, The Week US

 Devika Rao has worked as a staff writer at The Week since 2022, covering science, the environment, climate and business. She previously worked as a policy associate for a nonprofit organization advocating for environmental action from a business perspective.